Satellos Bioscience Inc.
MSCLF
$0.49
-$0.01-1.20%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.93M | -22.74M | -21.55M | -20.54M | -20.98M |
| Total Depreciation and Amortization | 12.60K | 11.60K | 13.60K | 14.60K | 7.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.46M | 3.63M | 3.44M | 2.64M | 5.33M |
| Change in Net Operating Assets | -1.45M | -1.93M | -2.37M | -733.80K | 750.40K |
| Cash from Operations | -21.91M | -21.02M | -20.46M | -18.61M | -14.89M |
| Capital Expenditure | -6.00K | -3.00K | -3.00K | -4.00K | -4.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.16M | 13.15M | 6.67M | 5.30M | 720.30K |
| Cash from Investing | -15.16M | 13.15M | 6.66M | 5.29M | 715.60K |
| Total Debt Issued | -- | -- | -- | -- | 140.00K |
| Total Debt Repaid | -- | -- | -- | -- | -237.00K |
| Issuance of Common Stock | 45.49M | 44.96M | 43.58M | 43.58M | 2.87M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.85M | 9.85M | 9.85M | 9.85M | -3.19M |
| Cash from Financing | 40.13M | 39.60M | 38.22M | 38.22M | -262.00K |
| Foreign Exchange rate Adjustments | 629.90K | 1.09M | 359.90K | 240.90K | -1.20M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.69M | 32.81M | 24.78M | 25.14M | -15.63M |